Brigham Hyde PhD

Dr. Brigham Hyde is CEO and co-founder of Atropos Health since August 2022. He provided funding and support for Atropos Health’s official launch in late 2020. Hyde has a significant track record of building businesses in the health tech and real-world data (RWD) space and most recently served as President of Data & Analytics at Eversana. Prior to that role, Mr. Hyde served as a healthcare partner at the AI venture fund Symphony AI, where he led the investment in, co-founded, and operated Concert AI, an oncology RWD company – most recently valued at $1.9B. Hyde held previous roles as Chief Data Offic